Detailed Information

Cited 710 time in webofscience Cited 798 time in scopus
Metadata Downloads

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME (R) trial

Authors
Fitchett, DavidZinman, BernardWanner, ChristophLachin, John M.Hantel, StefanSalsali, AfshinJohansen, Odd ErikWoerle, Hans J.Broedl, Uli C.Inzucchi, Silvio E.EMPA-REG OUTCOME trial investiorsAizenberg, D.Ulla, M.Waitman, J.De Loredo, L.Farias, J.Fideleff, H.Lagrutta, M.Maldonado, N.Colombo, H.Ferre Pacora, F.Wasserman, A.Maffei, L.Lehman, R.Selvanayagam, J.d'Emden, M.Fasching, P.Paulweber, B.Toplak, H.Luger, A.Drexel, H.Prager, R.Schnack, C.Schernthaner, G.Fliesser-Goerzer, E.Kaser, S.Scheen, A.Van Gaal, L.Hollanders, G.Kockaerts, Y.Capiau, L.Chachati, A.Persu, A.Hermans, M.Vantroyen, D.Vercammen, C.Van de Borne, P.Mathieu, C.Benhalima, K.Lienart, F.Mortelmans, J.Strivay, M.Vereecken, G.Keymeulen, B.Lamkanfi, F.Chacra, A.Eliaschewitz, F.Zanella, M.Faludi, A.Bertolami, M.Hayashida, C.Nunes Salles, J.Monte, O.Dinato, M.Manenti, E.Rassi, N.Halpern, A.Lima Filho, M.Ayoub, J.Felicio, J.Borges, J.Gross, J.Sgarbi, J.Betti, R.Tiburcio, A.Purisch, S.Schmid, H.Takahashi, M.Castro, M.Rea, R.Hissa, M.Geloneze Neto, B.Saraiva, J.Henein, S.Lochnan, H.Imran, S. A.Clayton, D.Bayly, K.Berlingieri, J.Boucher, P.Chan, Y.Gupta, M.Chehayeb, R.Ouellett, A.Ur, E.Woo, V.Zinman, B.St Amour, E.Terront Lozano, M.Yupanqui Lozno, H.Urina, M.Lopez Jaramillo, P.Jaramillo, N.Sanchez, G.Perez, G.Tusek, S.Mirosevic, G.Goldoni, V.Jurisic-Erzen, D.Balasko, A.Balic, S.Drvodelic-Sunic, E.Varzic, S. CaneckiMachkova, M.Weiner, P.Lastuvka, J.Olsovsky, J.Krarup, T.Ridderstrale, M.Tarnow, L.Boesgaard, T. WellovLihn, A. SaetreChristensen, P.Juhl, H.Urhammer, S.Lund, P.Adojaan, B.Jakovlev, U.Lanno, R.Lubi, M.Marandi, T.Gouet, D.Courreges, J.Zaoui, P.Choukroun, G.Petit, C.Formagne, L.Estour, B.Mabire, P.Daugenet, C.Lemarie, B.Clavel, S.Aure, P.Remaud, P.Halimi, J.Hadjadj, S.Couffinhal, T.Glonti, S.Metreveli, D.Lominadze, Z.Giorgadze, E.Burtchuladze, T.Javashvili, L.Kurashvili, G.Kurashvili, R.Virsaladze, D.Nadareishvili, L.Khomasuridze, A.Cahill, T.Green, F.MacRury, S.Waldron, M.Middleton, A.McKnight, J.Pearson, E.Butler, M.Choksi, M.Caldwell, I.Farmer, I.Wyatt, N.Patrick, J.O'Brien, I.Devers, M.Bousboulas, S.Pappas, S.Piaditis, G.Vryonidou, A.Tentolouris, N.Karamitsos, K.Manes, C.Benroubi, M.Avramidis, I.Ozaki, R.Tan, K.Siu, S.Tsang, C.Dudas, M.Nagy, K.Salamon, C.Ip, T.Geroo, L.Patkay, J.Tabak, A.Juhasz, F.Szentpeteri, I.Tamas, G.Ghaisas, N.Bantwal, G.Mohan, V.Gupta, J.Sadhu, N.Kulkarni, A.Garg, N.Reddy, S.Deshpande, N.Gutlapalli, K.Pillai, M.Premchand, R.Badgandi, M.Jain, S.Aravind, S.Shamanna, P.Pandey, A.Gupta, S.Pramono, B.Saksono, H. DanteAgung, P.Wahono, S. DjokoSuastika, K.Tanggo, Y.Juwana, Y.Siswanto, B.Adawi, F.Efrati, S.Mazen, E.Bashkin, A.Herskovits, T.Jaffe, A.Schiff, E.Wainstein, J.Taddei, S.Aiello, A.Arca, M.Calabro, P.Cignarelli, M.Fioretto, P.Reggiani, G. MarchesiniGnasso, A.Marchionni, N.Marsilii, A.Bucci, M.Mezzetti, A.Pozzilli, P.Colivicchi, F.Santini, M.Moro, E.Toscano, V.Fucili, A.Semplicini, A.Monno, S.Furui, K.Higashiue, S.Hiramatsu, N.Kawamitsu, K.Takenaka, T.Takahashi, H.Hojo, F.Onishi, Y.Izumino, K.Okubo, M.Wakida, Y.Kondo, Y.Hieshima, K.Jinnouchi, H.Suzuki, A.Ito, M.Park, S.Kim, Y.Hong, T.Park, H.Gwon, H.Kim, H.Kang, K.Jeong, M.Seung, K.Lim, D.Rha, S.Tahk, S.Yang, J.Yoon, J.Shin, M.Kim, D.Jeong, J.Ahmad, N. NikMustafa, N.Mohamed, W. WanFung, Y.Ghani, R. AbdulChandramouli, A.Chee, K.Kadir, K. AbdulLing, K.Abu Hassan, M.Foo, S.Lee, S.Garcia Hernandez, P.Aguilar-Salinas, C.Vidrio Velazquez, M.Flores, F.Alpizar Salazar, M.Micher Escalante, D.Garcia Soria, M.Cardona Munoz, E.Storms, G.Schaper, N.Kooy, A.Krekels, M.van Bemmel, T.Verhoeven, R.Mulder, H.Oldenburg-Ligtenberg, P.Gonkel, F.de Jong, A.van Soest, J.Viergever, P.Mevissen, H.Lochorn, G.Zwiers, G.Hoogslag, P.Ronner, E.Nierop, P.Al-Windy, N.Kragten, J.Dekelver, P.Benatar, J.Krebs, J.Scott, R.Heggen, E.Berz, A.Fossum, C.Hurtig, U.Langslet, G.Baranowski, M.Sparby, J.Karlsson, T.Karlsson, ThomasDelgado Torres, C.Rodriguez Escudero, A.Lisson, R.Allemant Maldonado, A.Gallardo Rojas, W.Gonzales Bravo, L.Lema Osores, J.Farfan, J.Zapata, L.Godoy Junchaya, J.Roldan Concha, Y.Urquiaga Calderon, J.Sy, R.Tan, G.Aquitania, G.De Los Santos, G.Panelo, A.Roderos, O.Rosales, R.Toledo, R.Liwag, A.Ramoncito, H.Skokowska, E.Krzyzagorska, E.Ogorek, M.Wojnowski, L.Spyra, J.Konieczny, M.Piesiewicz, W.Kus, W.Ocicka-Kozakiewicz, A.Orlowska-Kunikowska, E.Zmuda, W.Duarte, S.Leitao, A.Monteiro, P.Rita, H.Salgado, V.Pinto, L.Queiros, J.Teixeira, J.Rogado, C.Duarte, R.Sobral do Rosario, F.Silva, A.Andrade, L.Velez, M.Brazao, M.Istratoaie, O.Lichiardopol, R.Catrinoiu, D.Militaru, C.Zetu, C.Barbonta, D.Cosma, D.Crisan, C.Pop, L.Esip, V.Khetagurova, F.Petrov, A.Arutyunov, G.Boyarkin, M.Agafyina, A.Vorokhobina, N.Petunina, N.Libov, I.Zalevskaya, A.Nikolaev, K.Barbarash, O.Potemkin, V.Bystrova, A.Krasilnikova, E.Barbarich, V.Chumakova, G.Tarasov, N.Meleshkevich, T.Zateyshchikov, D.Lantseva, O.Belenkiy, D.Obrezan, A.Rossolko, L.Fillipova, E.Yakhontova, P.Khokhlov, A.Tan, R.Sum, C.Chang, H.Distiller, L.Pretorius, M.Nortje, H.Mitha, E.Burgess, L.Blignaut, S.Venter, T.Moodley, R.Lombaard, J.Govind, U.Naidoo, V.Mookadam, M.Engelbrecht, J.Omar, M.Jurgens, J.Podgorski, G.Vawda, H.Naidoo, D.Emanuel, S.Roodt, A.Amod, A.Van Zyl, L.Segura, J.Brito, M.Fernandez-Cruz, A.Artola, S.Iglesias, R.Toural, E.Garcia-Ortiz, L.Saban, J.Mesa, J.Vidal, J.Linares, J.del Canizo, F.Rigla, M.Suarez, C.Llorente, I.Moreno, B.Antoli, A.Gomez Peralta, F.Iglesias, M.Pereg, V.de Teresa, L.Camafort, M.Trescoli, C.Satarasinghe, R.Somasundaram, N.Siyambalapitiya, S.Antonypillai, C.Bulugahapitiya, D.Medagama, U.Huang, C.Lu, Y.Hwang, J.Chiang, C.Wen, M.Chen, J.Lai, W.Chang, K.Wang, J.Yeh, H.Kriangsak, P.Deerochanawong, C.Suwanwalaikorn, S.Mangklabruks, A.Kaewsuwanna, P.Piyayotai, D.Iabluchanskyi, M.Samoylov, O.Godlevska, O.Kovalyova, O.Voloshyna, O.Tseluyko, V.Zotov, S.Vykhovanyuk, I.Dulgeroff, A.Mayfield, R.Zaniewski-Singh, M.Ullal, J.Aloi, J.De La Rosa, R.Mosely, J.Wittmer, B.Aronoff, S.Rosenfeld, J.Seidner, M.Warren, M.Fishman, N.Weiss, R.Arif, A.Sandberg, M.Lewis, D.Ball, E.Graf, R.Breton, C.Tamayo, R.Richards, R.Cefalu, W.Uwaifo, G.Zayour, D.Hoffman, J.Fitz-Patrick, D.Khan, B.Blaze, K.Bressler, P.Halpern, S.Chappell, D.Bergenstal, R.Cuddihy, R.Matfin, G.Freedman, Z.Gonzalez-Campoy, J.Lerman, S.Rendell, M.Sitar, S.Reeves, M.Howard, T.Soufer, J.Miranda-Palma, B.Laliotis, A.Shomali, M.Teltser, M.Hurley, D.Morawski, E.Cherlin, R.Houchin, V.Welch, M.Goytia-Leos, D.Syed, M.Kowaloff, E.Weinrauch, L.Peniston, J.Brockmyre, A.First, B.Feld, L.Huffman, D.Nassim, O.Gottschlich, G.Patel, A.Knopke, C.Hernandez, M.Diaz, J.Giugliano, G.Nicasio, J.Eagerton, D.Huntley, R.Reed, J., IIIMagee, M.Hippert, R.Sofley, C., Jr.Alzohaili, O.Levins, P.Anspach, R.Shah, S.Brusco, O.Naidu, J.Lindenbaum, J.Jacks, R.Hammond, G.Arena, C.Saxman, K.Mach, M.Kerstein, H.Kereiakes, D.Wahlen, J.Wehmeier, K.Chaykin, L.Rothman, J.Fogelfeld, L.Stroger, John H., Jr.Bittar, N.Rosenstock, J.Kayne, D.Navarro, J.Colfer, H.Mokshagundam, S.Shandilya, L.Connery, L.Wysham, C.Dela Llana, A.Jardula, M.MacAdams, M.Flippo, G.Heurich, E.Curtis, C.Sanders, D.Rawls, R.Velazquez, F.Osea, E.Mahood, K.Feldman, G.Eder, F.Riley, E.Fowler, W.Jain, M.Shepard, M.Schear, M.Barker, B.Strout, C.Obiekwe, O.Shanik, M.Green, C.Blakney, E.Roberson, K.Bretton, E.Pish, R.Kaveh, K.Maynard, B.Barager, W.Soldyshev, R.Austin, B.Parmar, P.Simpson, R.Chauhan, A.Kasper, J.Burr, R.Patel, N.Mariano, H.Pluto, T.Bratcher, C.Juarez, M.Levinson, L.Awad, A.Longshaw, K.Hoffman, K.Richwine, R.Molter, D.Boscia, J., IIIKowalyk, S.Lemis, P.Liss, J.Orr, R.Riser, J.Wood, J.Ubani, A.Paine, W.Hassani, F.Miranda, F.Hansen, V.Hansen, Val R.Farris, N.Bowden, R.Ajani, D.Maw, K.Andersen, J.Bergman, B.Dunmyer, S.Brandon, D.Anderson, M.Bononi, P.Prawer, J.Seidman, B.Cruz, H.Wilks, K.DiSanto, L.Buynak, R.Christensen, T.Denker, P.Koppel, W.Stedman, M.Lewy-Alterbaum, L.Karim, S.Shapiro, J.Gardner, T.Oskin, T.Gabra, N.Malano, J.
Issue Date
May-2016
Publisher
Oxford University Press
Keywords
Cardiovascular disease; Hospitalization; Mortality
Citation
European Heart Journal, v.37, no.19, pp 1526 - 1534
Pages
9
Indexed
SCI
SCIE
SCOPUS
Journal Title
European Heart Journal
Volume
37
Number
19
Start Page
1526
End Page
1534
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/52264
DOI
10.1093/eurheartj/ehv728
ISSN
0195-668X
1522-9645
Abstract
Aims We previously reported that in the EMPA-REG OUTCOME® trial, empagliflozin added to standard of care reduced the risk of 3-point major adverse cardiovascular events, cardiovascular and all-cause death, and hospitalization for heart failure in patients with type 2 diabetes and high cardiovascular risk. We have now further investigated heart failure outcomes in all patients and in subgroups, including patients with or without baseline heart failure. Methods and results Patients were randomized to receive empagliflozin 10 mg, empagliflozin 25 mg, or placebo. Seven thousand and twenty patients were treated; 706 (10.1%) had heart failure at baseline. Heart failure hospitalization or cardiovascular death occurred in a significantly lower percentage of patients treated with empagliflozin [265/4687 patients (5.7%)] than with placebo [198/2333 patients (8.5%)] [hazard ratio, HR: 0.66 (95% confidence interval: 0.55–0.79); P < 0.001], corresponding to a number needed to treat to prevent one heart failure hospitalization or cardiovascular death of 35 over 3 years. Consistent effects of empagliflozin were observed across subgroups defined by baseline characteristics, including patients with vs. without heart failure, and across categories of medications to treat diabetes and/or heart failure. Empagliflozin improved other heart failure outcomes, including hospitalization for or death from heart failure [2.8 vs. 4.5%; HR: 0.61 (0.47–0.79); P < 0.001] and was associated with a reduction in all-cause hospitalization [36.8 vs. 39.6%; HR: 0.89 (0.82–0.96); P = 0.003]. Serious adverse events and adverse events leading to discontinuation were reported by a higher proportion of patients with vs. without heart failure at baseline in both treatment groups, but were no more common with empagliflozin than with placebo. Conclusion In patients with type 2 diabetes and high cardiovascular risk, empagliflozin reduced heart failure hospitalization and cardiovascular death, with a consistent benefit in patients with and without baseline heart failure.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Cardiology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Rha, Seung Woon photo

Rha, Seung Woon
Guro Hospital (Department of Cardiology, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE